Compliance Question of the Week – Laboratory

Laboratory Question for the Week of December 24, 2018

We operate CLIA moderate-complexity laboratories. Our testing menu offers several otherwise CLIA-waived tests (e.g., influenza testing, Strep A testing, certain chemistry analyses) in addition to some moderate-complexity testing such as a complete blood count and blood gases.

Are we REQUIRED to use a -QW modifier on those waived tests, or are we simply ALLOWED to use the modifier but not otherwise required?

Read the Answer

Laboratory Question for the Week of December 17, 2018

The recommended practice is to confirm a new patient’s blood type with a repeat blood draw and retype done on the new specimen. This is only for a new patient or a patient who does not have type information already in the system. Is it appropriate to bill for the second blood type on a new patient, or is this considered confirmatory testing?

Read the Answer

CPT® copyright 2023 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’  is just $99 for a limited time! Use code WorldHealth24 at checkout.

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →